Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2SARS CoV-2에 감염된 환자의 잠재적인 항바이러스 치료 인도메타신의 투여 요법을 추정하기 위한 모델 기반 접근 방식Original Paper Published on 2020-05-202022-09-10 Journal: Journal of Pharmacokinetics and Pharmacodynamics [Category] MERS, SARS, 비임상, [키워드] administration anti-inflammatory drug antiviral activity antiviral property Antiviral treatment approach assumption benefit best breath canine Clinical dose Complete coronavirus criteria dosage dose dosing regimen dosing regimens drugs effective evaluated expected Human human SARS-CoV-2 identify In-vitro indomethacin Model Model-based Patient Prospective clinical trial regimen SARS CoV-2 SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 coronavirus SARS-CoV-2 pandemic shown supplementary material the SARS-CoV-2 therapeutic effect Translational model Treatment Viral Viral load [DOI] 10.1007/s10928-020-09690-4 PMC 바로가기 [Article Type] Original Paper
SARS-CoV-2 Infection with Different Radiological InsightsCase Report Published on 2020-05-072022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome affected anti-inflammatory drug anticoagulant therapy Antiviral ARDS characterized clinical condition Computed tomography death insight lung lung acute embolism Mild Patient radiological radiological finding SARS-CoV-2 severe acute respiratory syndrome-coronavirus-2 Symptom syndrome therapy viral infection [DOI] 10.3390/diagnostics10050283 PMC 바로가기 [Article Type] Case Report
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)Article Published on 2020-04-292022-11-01 Journal: Clinical microbiology and infection : the official [Category] COVID-19, SARS, [키워드] access acute respiratory syndrome Administered affected anti-inflammatory drug Antiviral approach balancing content coronavirus coronavirus disease COVID-19 COVID-19 patients Disease spectrum early phase enrolled Epidemic European Evidence IMPROVE intensive care Italian Italy management objective off-label Patient patients with COVID-19 physician Pneumonia provided Pulmonology randomized clinical trials Randomized controlled trial Region Respiratory failure SARS-CoV-2 secure selected Severe case Society Source Support supported supportive care symptomatic therapy Topic Treatment unlikely ventilator worsening [DOI] 10.1016/j.cmi.2020.04.031 PMC 바로가기 [Article Type] Article